Hematologic and cytogenetic response to lenalidomide monotherapy in acute myeloid leukemia arising from JAK2V617F positive, del(5)(q13q33) myelodysplastic syndrome [13]

R. A. Mesa, A. Tefferi, C. Yang Li, D. P. Steensma

Research output: Contribution to journalLetterpeer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Hematologic and cytogenetic response to lenalidomide monotherapy in acute myeloid leukemia arising from JAK2<sup>V617F</sup> positive, del(5)(q13q33) myelodysplastic syndrome [13]'. Together they form a unique fingerprint.